Institute of Human Virology at the University of Maryland School of Medicine, Baltimore, MD 21201, USA.
J Acquir Immune Defic Syndr. 2011 May 1;57(1):9-15. doi: 10.1097/QAI.0b013e3182100c1b.
To examine the relationship between HIV-1 antigenic load (plasma RNA copies/mL) and broad HIV-1 neutralizing antibody activity.
Plasma from 120 HIV-1-infected patients, including HIV-1 natural viral suppressors (similar to elite controllers), was tested for neutralization against 15 Tier 1/Tier 2 HIV-1 pseudoviruses. Broad HIV-1 neutralizing antibody activity was confirmed with immunoglobulin G and heterlogous clade testing (18 pseudoviruses from Clades A, C, and CRF02_AG). Statistical analysis was performed to determine factors associated with broad HIV-1 neutralizing antibody activity.
Ten individuals with broad HIV-1 neutralizing antibody activity were identified. These individuals had a median CD4 count of 589 cells per microliter (range 202-927), 1611 HIV-1 RNA copies per milliliter (range 110-8964), and 13 years since HIV diagnosis (range 1-22). There was a significant correlation between the presence of broadly neutralizing antibodies in those with HIV-1 RNA between 100 and 10,000 copies per milliliter compared with those <100 or >10,000 copies per milliliter (P = 0.0003 and 0.0245, respectively). Individuals with HIV-1 RNA 100-10,000 copies per milliliter had a higher number of Tier 2 viruses neutralized compared with the <100 or >10,000 copies per milliliter groups (P ≤ 0.0001 and P = 0.076, respectively). Male sex was associated with broad HIV-1 neutralizing antibody activity (P = 0.016).
These results indicate that low but persistent HIV antigen expression correlates with broad HIV-1 neutralizing antibody activity. At higher levels of plasma viremia, neutralization titers were diminished. Conversely, at lower levels, there seems to be insufficient antigen stimulation to maintain high neutralization titers. These findings may have important implications in furthering the understanding of the humoral response to HIV infection.
研究 HIV-1 抗原载量(血浆 RNA 拷贝数/ml)与广泛中和 HIV-1 抗体活性之间的关系。
对 120 例 HIV-1 感染者的血浆进行了 15 种 1 级/2 级 HIV-1 假病毒的中和试验。使用 IgG 和异源克隆检测(来自 A、C 和 CRF02_AG 组的 18 种假病毒)证实了广泛中和 HIV-1 抗体的活性。进行了统计学分析以确定与广泛中和 HIV-1 抗体活性相关的因素。
确定了 10 名具有广泛中和 HIV-1 抗体活性的个体。这些个体的中位 CD4 计数为每微升 589 个细胞(范围 202-927),每毫升 1611 个 HIV-1 RNA 拷贝(范围 110-8964),HIV 诊断后 13 年(范围 1-22)。在 HIV-1 RNA 为 100-10000 拷贝/ml 的个体中,与<100 或>10000 拷贝/ml 的个体相比,具有广泛中和抗体的存在有显著相关性(P=0.0003 和 0.0245)。HIV-1 RNA 为 100-10000 拷贝/ml 的个体中和的 2 级病毒数量高于<100 或>10000 拷贝/ml 的群体(P≤0.0001 和 P=0.076)。男性与广泛中和 HIV-1 抗体活性相关(P=0.016)。
这些结果表明,低但持续的 HIV 抗原表达与广泛中和 HIV-1 抗体活性相关。在更高水平的血浆病毒血症时,中和滴度降低。相反,在较低水平时,似乎没有足够的抗原刺激来维持高中和滴度。这些发现可能对进一步了解 HIV 感染的体液反应具有重要意义。